59 related articles for article (PubMed ID: 27269)
1. Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide.
Bekri S; Bley A; Brown HA; Chanson C; Church HJ; Gelb MH; Hong X; Janzen N; Kasper DC; Mechtler T; Morton G; Murko S; Oliva P; Tebani A; Wu THY
Mol Genet Metab; 2024 May; 142(1):108436. PubMed ID: 38552449
[TBL] [Abstract][Full Text] [Related]
2. Engineered arylsulfatase A with increased activity, stability and brain delivery for therapy of metachromatic leukodystrophy.
Yaghootfam C; Sylvester M; Turk B; Gieselmann V; Matzner U
Mol Ther; 2023 Oct; 31(10):2962-2974. PubMed ID: 37644722
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the Therapeutic Utility of Olaparib in Sulfatide-Induced Human Astrocyte Toxicity and Neuroinflammation.
Mekhaeil M; Conroy MJ; Dev KK
J Neuroimmune Pharmacol; 2023 Dec; 18(4):592-609. PubMed ID: 37924373
[TBL] [Abstract][Full Text] [Related]
5. Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry.
Barcenas M; Suhr TR; Scott CR; Turecek F; Gelb MH
Clin Chim Acta; 2014 Jun; 433():39-43. PubMed ID: 24370383
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening in metachromatic leukodystrophy - European consensus-based recommendations on clinical management.
Laugwitz L; Schoenmakers DH; Adang LA; Beck-Woedl S; Bergner C; Bernard G; Bley A; Boyer A; Calbi V; Dekker H; Eichler F; Eklund E; Fumagalli F; Gavazzi F; Grønborg SW; van Hasselt P; Langeveld M; Lindemans C; Mochel F; Oberg A; Ram D; Saunier-Vivar E; Schöls L; Scholz M; Sevin C; Zerem A; Wolf NI; Groeschel S
Eur J Paediatr Neurol; 2024 Mar; 49():141-154. PubMed ID: 38554683
[TBL] [Abstract][Full Text] [Related]
7. Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.
Farah MH; Dali CÍ; Groeschel S; Moldovan M; Whiteman DAH; Malanga CJ; Krägeloh-Mann I; Li J; Barton N; Krarup C
Ann Clin Transl Neurol; 2024 Feb; 11(2):328-341. PubMed ID: 38146590
[TBL] [Abstract][Full Text] [Related]
8. Long-term disease course of two patients with multiple sulfatase deficiency differs from metachromatic leukodystrophy in a broad cohort.
Beck-Wödl S; Kehrer C; Harzer K; Haack TB; Bürger F; Haas D; Rieß A; Groeschel S; Krägeloh-Mann I; Böhringer J
JIMD Rep; 2021 Mar; 58(1):80-88. PubMed ID: 33728250
[TBL] [Abstract][Full Text] [Related]
9. Insight into adult-onset metachromatic leukodystrophy with optic atrophy: A comprehensive case report.
Katwal S; Suwal S; Lamichhane S; Bhusal A; Ghimire A
Radiol Case Rep; 2023 Nov; 18(11):4182-4186. PubMed ID: 37745772
[TBL] [Abstract][Full Text] [Related]
10. Dose-response evaluation of intravenous gene therapy in a symptomatic mouse model of metachromatic leukodystrophy.
Audouard E; Khefif N; Mansat C; Nelcha O; Banchi EG; Lupiet C; Farabos D; Lamaziere A; Sevin C; Piguet F
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101248. PubMed ID: 38680552
[TBL] [Abstract][Full Text] [Related]
11. Early discoveries on enzyme deficiencies in lysosomal storage diseases: The Indian contribution.
Gupta S; Bachhawat AK
J Biosci; 2023; 48():. PubMed ID: 38088379
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing.
Dustin E; McQuiston AR; Honke K; Palavicini JP; Han X; Dupree JL
Glia; 2023 Sep; 71(9):2285-2303. PubMed ID: 37283058
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy.
Singh N; Singh AK
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128780. PubMed ID: 38104688
[TBL] [Abstract][Full Text] [Related]
14. Differential binding patterns of anti-sulfatide antibodies to glial membranes.
Meehan GR; McGonigal R; Cunningham ME; Wang Y; Barrie JA; Halstead SK; Gourlay D; Yao D; Willison HJ
J Neuroimmunol; 2018 Oct; 323():28-35. PubMed ID: 30196830
[TBL] [Abstract][Full Text] [Related]
15. Sulfatide Deficiency, an Early Alzheimer's Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks.
Palavicini JP; Ding L; Pan M; Qiu S; Wang H; Shen Q; Dupree JL; Han X
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613677
[TBL] [Abstract][Full Text] [Related]
16. Importance of C24:2 sulfatide.
Thea R; Buschard K
APMIS; 2024 Jul; 132(7):530-531. PubMed ID: 38588562
[No Abstract] [Full Text] [Related]
17. [Pathophysiology of sulfatide metabolism in metachromatic leukodystrophy].
Wiesmann UN
Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):33-47. PubMed ID: 27269
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution.
Wittke D; Hartmann D; Gieselmann V; Lüllmann-Rauch R
Acta Neuropathol; 2004 Oct; 108(4):261-71. PubMed ID: 15322834
[TBL] [Abstract][Full Text] [Related]
19. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder.
Saravanan K; Schaeren-Wiemers N; Klein D; Sandhoff R; Schwarz A; Yaghootfam A; Gieselmann V; Franken S
Neurobiol Dis; 2004 Jul; 16(2):396-406. PubMed ID: 15193296
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
